Date published: 2025-9-26

1-800-457-3801

SCBT Portrait Logo
Seach Input

Iodixanol (CAS 92339-11-2)

0.0(0)
Write a reviewAsk a question

See product citations (1)

Alternate Names:
5,5-[(2-Hydroxy-1,3-propanediyl)bis(acetylimino)]bis[N,N-bis(2,3-dihydroxypropyl)-2,4,6-triiodo-1,3-benzenedicarboxamide; 2-5410-3A; OptiPrep; Visipaque
Application:
Iodixanol is a radiopaque medium
CAS Number:
92339-11-2
Molecular Weight:
1550.18
Molecular Formula:
C35H44I6N6O15
For Research Use Only. Not Intended for Diagnostic or Therapeutic Use.
* Refer to Certificate of Analysis for lot specific data.

QUICK LINKS

Iodixanol is a non-ionic, iso-osmolar contrast agent primarily utilized in the field of research for diagnostic imaging, including X-ray and computed tomography (CT) scans, to enhance the visualization of body structures such as blood vessels, organs, and tissues. Its mechanism of action involves the high atomic number of iodine, which allows iodixanol to absorb X-rays more effectively than surrounding tissues, thereby creating a contrast that delineates anatomical features with greater clarity. This characteristic makes it invaluable for studies aimed at understanding the intricate details of vascular diseases, the architecture of organ systems, and the progression of pathologies in model organisms. Iodixanol′s iso-osmolar property, where its osmolality is similar to that of blood, minimizes the risk of osmotic shock in experimental applications, making it a preferred choice for applications requiring high fidelity and minimal physiological disturbance to the subjects under examination. Its role in research extends beyond mere imaging enhancement to include applications in cell biology, where it is used in density gradient centrifugation for the separation and purification of cells, viruses, and subcellular organelles, thereby contributing to a broader understanding of cellular functions and disease mechanisms.


Iodixanol (CAS 92339-11-2) References

  1. Renal safety of iodixanol.  |  McCullough, PA. 2006. Expert Rev Cardiovasc Ther. 4: 655-61. PMID: 17081087
  2. The relative renal safety of iodixanol compared with low-osmolar contrast media: a meta-analysis of randomized controlled trials.  |  Reed, M., et al. 2009. JACC Cardiovasc Interv. 2: 645-54. PMID: 19628188
  3. A meta-analysis of the risk of total cardiovascular events of isosmolar iodixanol compared with low-osmolar contrast media.  |  Zhang, BC., et al. 2014. J Cardiol. 63: 260-8. PMID: 24397991
  4. Comparative Analysis of Cesium Chloride- and Iodixanol-Based Purification of Recombinant Adeno-Associated Viral Vectors for Preclinical Applications.  |  Strobel, B., et al. 2015. Hum Gene Ther Methods. 26: 147-57. PMID: 26222983
  5. Iodixanol versus iopromide in patients with renal insufficiency undergoing coronary angiography with or without PCI.  |  Zhang, J., et al. 2018. Medicine (Baltimore). 97: e0617. PMID: 29718868
  6. Iodixanol supplementation during sperm cryopreservation improves protamine level and reduces reactive oxygen species of canine sperm.  |  Abdillah, DA., et al. 2019. J Vet Sci. 20: 79-86. PMID: 30481988
  7. Adeno-Associated Virus Production, Purification, and Titering.  |  Chen, YH., et al. 2018. Curr Protoc Mouse Biol. 8: e56. PMID: 30489697
  8. Evaluation of synergic effects of iodixanol and trehalose on cryosurvival of electroejaculated ram semen.  |  Özmen, MF., et al. 2020. Andrologia. 52: e13656. PMID: 32478874
  9. Iodixanol activation of mast cells: Implications in the pathogenesis of iodixanol-induced delayed cutaneous adverse reactions.  |  Zou, W., et al. 2022. Toxicology. 465: 153034. PMID: 34774977
  10. Recurrent Iodixanol-induced Transitory Mental Disorder in a Woman After Percutaneous Coronary Intervention.  |  Wang, H. and Zhong, L. 2022. Neurol India. 70: 1678-1679. PMID: 36076686
  11. Physicochemical properties of iodixanol.  |  Eivindvik, K. and Sjogren, CE. 1995. Acta Radiol Suppl. 399: 32-8. PMID: 8610527
  12. Safety, tolerance, and pharmacokinetics of iodixanol injection, a nonionic, isosmolar, hexa-iodinated contrast agent.  |  Fountaine, H., et al. 1996. Acad Radiol. 3 Suppl 3: S475-84. PMID: 8883524
  13. Iodixanol. A review of its pharmacodynamic and pharmacokinetic properties and diagnostic use as an x-ray contrast medium.  |  Spencer, CM. and Goa, KL. 1996. Drugs. 52: 899-927. PMID: 8957160

Ordering Information

Product NameCatalog #UNITPriceQtyFAVORITES

Iodixanol, 10 mg

sc-211651
10 mg
$291.00

Iodixanol, 100 mg

sc-211651A
100 mg
$1963.00

Iodixanol, 1 kg

sc-211651B
1 kg
$6635.00

Iodixanol, 5 kg

sc-211651C
5 kg
$19895.00

Iodixanol, 10 kg

sc-211651D
10 kg
$26879.00

Iodixanol, 25 kg

sc-211651E
25 kg
$40295.00